Price T Rowe Associates Inc Olink Holding Ab (Publ) Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$21.87 - $25.59 $33,548 - $39,255	1,534 Added 0.18%	869,828 $22.2 Million
Q1 2024 May 15, 2024	BUY	$21.81 - $25.14 $45,757 - $52,743	2,098 Added 0.24%	868,294 $20.4 Million
Q4 2023 Feb 14, 2024	SELL	$14.29 - $25.95 $132 Million - $239 Million	-9,214,171 Reduced 91.41%	866,196 $21.8 Million
Q3 2023 Nov 14, 2023	BUY	$14.45 - $20.34 $386,060 - $543,423	26,717 Added 0.27%	10,080,367 $149 Million
Q2 2023 Aug 14, 2023	BUY	$17.13 - $23.74 $9.5 Million - $13.2 Million	554,295 Added 5.84%	10,053,650 $189 Million
Q1 2023 May 15, 2023	BUY	$19.34 - $24.11 $36.8 Million - $45.9 Million	1,905,330 Added 25.09%	9,499,355 $214 Million
Q4 2022 Feb 14, 2023	BUY	$12.64 - $25.52 $396,036 - $799,592	31,332 Added 0.41%	7,594,025 $193 Million
Q3 2022 Nov 14, 2022	SELL	$12.14 - $18.42 $25.6 Million - $38.8 Million	-2,108,146 Reduced 21.8%	7,562,693 $91.8 Million
Q2 2022 Aug 15, 2022	SELL	$8.95 - $19.24 $100,633 - $216,334	-11,244 Reduced 0.12%	9,670,839 $147 Million
Q1 2022 May 16, 2022	BUY	$11.33 - $19.3 $2.96 Million - $5.04 Million	261,233 Added 2.77%	9,682,083 $171 Million
Q4 2021 Feb 14, 2022	BUY	$18.0 - $34.82 $44.5 Million - $86.2 Million	2,474,187 Added 35.62%	9,420,850 $171 Million
Q3 2021 Nov 15, 2021	BUY	$23.42 - $37.93 $69.9 Million - $113 Million	2,985,095 Added 75.35%	6,946,663 $168 Million
Q2 2021 Aug 16, 2021	BUY	$26.65 - $39.47 $3.85 Million - $5.7 Million	144,456 Added 3.78%	3,961,568 $136 Million
Q1 2021 May 17, 2021	BUY	$31.9 - $36.0 $122 Million - $137 Million	3,817,112 New	3,817,112 $137 Million

Others Institutions Holding OLK

# of Institutions

Shares Held

15.9M

Call Options Held

34.9K

Put Options Held

110K

View Full List

About Olink Holding AB (publ)

Ticker OLK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 119,098,000
Description
Olink Holding AB (publ) provides various products and services for the academic, government, biopharmaceutical, biotechnology, and other institutions that focuses on life science research. Its products include Olink Explore for cardiovascular and metabolic, oncology, neurology, or inflammation diseases; Olink Target product line; and Olink Focus...

More about OLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account